Zhejiang Huakang Stock Soars 7.2%, Hits Intraday High of CNY 16.57

Zhejiang Huakang Pharmaceutical Co., Ltd. has experienced a notable increase of 7.2% on March 6, 2026, reaching an intraday high of CNY 16.57. This performance stands in contrast to the China Shanghai Composite, which saw a modest gain of 0.38% on the same day. Despite the positive movement today, the stock has faced challenges over the past week, with a decline of 2.5%. Over the last month, it has shown a slight increase of 0.74%, while its year-to-date performance is more favorable at 10.76%. However, the stock has underperformed over the longer term, with a three-year decline of 26.97% and a five-year drop of 52.49%. Financial metrics indicate that the company has a market capitalization of CNY 4,755 million and a price-to-earnings ratio of 21.00. The return on equity stands at 7.76%, and the company offers a dividend yield of 4.41%. Despite recent gains, the overall performance suggests a mixed outlook for Zhejiang Huakang Pharmaceutical in the competitive pharmaceuticals and biotechnology sector.